Obesity, insulin resistance, and cardiovascular disease.
about
Developmental exposure of rats to chlorpyrifos elicits sex-selective hyperlipidemia and hyperinsulinemia in adulthood.Metabolic disorders in menopauseBile acid metabolism and signalingThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceReducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education ProgramAssociation of adipocyte genes with ASP expression: a microarray analysis of subcutaneous and omental adipose tissue in morbidly obese subjects.Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review.Thylakoids promote release of the satiety hormone cholecystokinin while reducing insulin in healthy humans.Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional studyEffects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabeticsAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study.Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome.The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase.Drosophila ste-20 family protein kinase, hippo, modulates fat cell proliferation.Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c.Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes.Subcutaneous adipose cell size and distribution: relationship to insulin resistance and body fatThe effect of heat treatment of thylakoids on their ability to inhibit in vitro lipase/co-lipase activity.Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trialBiochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats.Sleep disorder and cardiovascular risk factors among patients with type 2 diabetes mellitusImpact of breathing awareness meditation on ambulatory blood pressure and sodium handling in prehypertensive African American adolescents.Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndromeClinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.Meat Intake and Insulin Resistance in Women without Type 2 Diabetes.Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients?Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice.Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.Obesity-related cardiovascular disease: implications of obstructive sleep apnea.Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome.Role of fat body lipogenesis in protection against the effects of caloric overload in DrosophilaObstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its componentsAdiponectin in severe preeclampsia.Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation
P2860
Q24815944-785B44CE-A2AC-41A2-8964-C8D0567F1634Q26795571-E5F78D9A-84E4-4340-91A7-905CE25CADFEQ27002873-FFA87725-E5A1-4F26-A1C3-87D087834137Q27003277-D67F3656-49AD-4663-A022-6EEA961C08DFQ28201111-D74030A8-4F43-449D-B39E-540A337997A3Q30384917-EBABFE5C-408A-4A61-A2C3-F2B0DDF12CE0Q30429027-6AF270ED-461C-4435-8897-ACD4007D67F9Q30443817-1E408C58-2850-4BCD-9A43-52D79FEB6FF5Q30859894-C0F43891-FCA4-4978-8E99-ACE2C3C46D85Q33273785-CC118BEF-9CDC-4436-BA46-8E64D4261AC4Q33965753-307EAE54-84D7-4D2D-AB98-3F88ED1FC255Q34002877-DAF9AD1F-10AF-4A45-B7F5-98BA22469F77Q34054063-BC783FBB-7714-49F1-A177-CCB6A0B5F0DEQ34174638-8412CEA3-33A8-4F08-83F1-EEB367ECE67CQ34180196-1C98B286-E5B5-487A-8C06-4D881FC587EBQ34449870-322EF8E3-F5F0-4124-A52C-57667AB1F890Q34478554-EFEC308B-E8C0-4604-8F1F-850BF50E59CAQ34700613-0740BB5D-4657-40E0-A1F8-18BF45CF1849Q35049218-57786E31-2170-4297-BACF-0B47E2E7020FQ35078114-C63268C5-DF47-4ACE-8D4D-496BB542E61CQ35130591-4F857913-8B9B-4CED-A428-B78953189EECQ35205984-FE00503E-CA0B-4F55-AECB-F9C84543D021Q35208623-E9B0BB29-6744-4C28-AA36-A854CA852FD7Q35217867-8EA1BE5C-B2CD-4857-8EE3-A7482D6C1E08Q35331587-96479936-115F-4719-963E-312D459883B0Q35549934-5703D3A0-C31B-48E0-B81A-B941104D619CQ35753018-7CE1FA27-2F59-4D77-A1E2-6B3A3ED81AEBQ35786266-392DACD8-F572-4593-83FC-F3FB32607CE9Q35811703-6BC09B8D-4517-4CE9-AAD3-F90FE576B2A0Q35882491-52AE5DED-F3FB-42CF-92A3-A89E21981BFFQ36207896-545E042A-2F52-48E7-B8A1-9D4AD8FB93A6Q36232568-CA916AA7-1093-4AE3-BE16-BB1DBA10AF8EQ36283807-367BDC0D-774F-4AFF-BC1F-E96843D6C4D0Q36435617-1E5B81F5-905D-47BB-A31B-CE34D2E54DF1Q36458545-9094F008-9F82-4C31-84ED-280E883F01ADQ36579391-4E2EFEB1-D836-44C6-9091-9BB1F0DCAD4CQ36708470-84FF9072-AEB5-47B3-8911-7C74A2AC615BQ36897409-099099B1-623E-40DE-B44B-FCA6DAC334E6Q36946738-32B346DC-23FD-47B9-8EA1-C383BA18C1DAQ36950689-10D649A1-A012-429A-BD72-CE411DC74AF0
P2860
Obesity, insulin resistance, and cardiovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Obesity, insulin resistance, and cardiovascular disease.
@ast
Obesity, insulin resistance, and cardiovascular disease.
@en
type
label
Obesity, insulin resistance, and cardiovascular disease.
@ast
Obesity, insulin resistance, and cardiovascular disease.
@en
prefLabel
Obesity, insulin resistance, and cardiovascular disease.
@ast
Obesity, insulin resistance, and cardiovascular disease.
@en
P921
P356
P1433
P1476
Obesity, insulin resistance, and cardiovascular disease.
@en
P2093
Fahim Abbasi
Tracey McLaughlin
P304
P356
10.1210/RP.59.1.207
P577
2004-01-01T00:00:00Z